Skip to primary navigation
Skip to main content
Skip to footer
Neurotech International
ASX:NTI
Home
Corporate
Board and Management
Corporate Directory
Corporate Governance
Development Programs
Biopharmaceutical Trials
Combination Therapy
Pathways to Commercialisation
Mente Technology
Investors
Investor Dashboard
ASX Announcements
Company Reports
Presentations
Research
News & Media
Contact
Gerald Quigley, short discussion on 4RO Rockhampton regarding Autism
2 August 2022
News & Media
4RO
Download prospectus
CLOSE
